Used in research and development for targeted therapies, particularly in oncology. Shows potential in modulating immune responses by binding specifically to SLITRK6, a protein overexpressed in certain cancers such as bladder and lung tumors. Enables precise delivery of therapeutic agents when conjugated with drugs or toxins, enhancing tumor cell killing while minimizing damage to healthy tissues. Also utilized in diagnostic imaging to detect SLITRK6-positive tumors. Supports studies on neural development due to SLITRK6's role in the nervous system, aiding exploration of neurodegenerative and psychiatric disorders.